Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Pigment Cell & Melanoma Research|October 8, 2011
A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasisM P O'Connell, A T WeeraratnaThe Prostate|June 22, 2000
Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cellsB Tombal, A T Weeraratna, S R Denmeade, et al.The Prostate|October 12, 2000
Rational basis for Trk inhibition therapy for prostate cancerA T Weeraratna, J T Arnold, D J George, et al.Oncogene|October 31, 2006
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cellsJ Li, W H Wood, K G Becker, et al.Cancer Research|September 2, 2000
Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinasesF A Attiga, P M Fernandez, A T Weeraratna, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Loss of uteroglobin expression in prostate cancer: relationship to advancing gradeA T Weeraratna, J A Cajigas, A Schwartz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cellsA T Weeraratna, S L Dalrymple, J C Lamb, et al.Oncogene|October 6, 2009
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanomaM P O'Connell, J L Fiori, M Xu, et al.Oncogene|December 13, 2006
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motilityP D Leotlela, M S Wade, P H Duray, et al.Pageof 1